We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $832M
1-Year Est. Return 32.38%
This Fund
S&P 500
This Quarter Est. Return
+0.69%
1 Year Est. Return
+32.38%
3 Year Est. Return
+137.31%
5 Year Est. Return
+86.76%
10 Year Est. Return
–
AUM
$4.47B
AUM Growth
+$882M
Cap. Flow
+$887M
Cap. Flow %
19.84%
Top 10 Hldgs %
65.97%
Holding
43
New
13
Increased
6
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
EDU icon
New Oriental
EDU
+$152M
2
WUBA
58.com Inc
WUBA
+$152M
3
TSLA icon
Tesla
TSLA
+$122M
4
PDD icon
Pinduoduo
PDD
+$88M
5
BILI icon
Bilibili
BILI
+$74.9M

Top Sells

Rank Stock Value
1
MDLZ icon
Mondelez International
MDLZ
+$24.3M

Sector Composition

Rank Sector Weight
1 Healthcare 30.72%
2 Consumer Discretionary 27.6%
3 Communication Services 21.72%
4 Consumer Staples 17.35%
5 Financials 2.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GTHX
26
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$29.1M 0.65%
949,431
– –
KNSA icon
27
Kiniksa Pharmaceuticals
KNSA
$5.86B
$24.9M 0.56%
1,835,888
– –
TME icon
28
Tencent Music
TME
$12.9B
$22M 0.49%
1,470,491
– –
GOSS icon
29
Gossamer Bio
GOSS
$63.4M
$20.8M 0.47%
11,719
– –
ZM icon
30
Zoom
ZM
$27.2B
$20M 0.45%
+225,000
New +$18.5M
MOGU
31
MOGU Inc
MOGU
$15.4M
$14.9M 0.33%
+435,290
New +$35.5M
ARVN icon
32
Arvinas
ARVN
$540M
$13.7M 0.31%
625,000
– –
SOHU
33
Sohu.com
SOHU
$359M
$11.2M 0.25%
802,034
– –
RGNX icon
34
Regenxbio
RGNX
$525M
$10.6M 0.24%
+206,000
New +$10.3M
AKRO
35
DELISTED
Akero Therapeutics
AKRO
$8.14M 0.18%
+425,000
New +$8.06M
EIDX
36
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$5.55M 0.12%
178,600
– –
RCUS icon
37
Arcus Biosciences
RCUS
$3.1B
$3.38M 0.08%
425,000
– –
BYND icon
38
Beyond Meat
BYND
$172M
$2.41M 0.05%
+500
New +$1.67M
HOOK
39
DELISTED
HOOKIPA Pharma
HOOK
$1.92M 0.04%
+28,571
New +$3.03M
NXTC icon
40
NextCure
NXTC
$29.2M
$1.12M 0.03%
+6,250
New +$1.3M
CIH
41
DELISTED
China Index Holdings Limited American Depository Shares
CIH
$1.06M 0.02%
+300,000
New +$1.01M
SFUN
42
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$932K 0.02%
30,000
– –
NEW
43
DELISTED
Puxin Limited American Depositary Shares, each representing twenty Ordinary Shares
NEW
$792K 0.02%
12,615
– –
1
2

Similar funds

ACGDR
Atmos Capital Gestao de Recursos Leblon - Rio De Janeiro, Brazil $832M AUM 5.47% 1-Year Est. Return
NCM
Noesis Capital Mangement Boca Raton, Florida $832M AUM 49.88% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
AFA
AA Financial Advisors Columbus, Ohio $832M AUM 20.55% 1-Year Est. Return
BEC
Blue Edge Capital Richmond, Virginia $833M AUM 25.55% 1-Year Est. Return
AFA
American Financial Advisors Marietta, Georgia $831M AUM 21.38% 1-Year Est. Return
BCG
Breakwater Capital Group Paramus, New Jersey $833M AUM 22.71% 1-Year Est. Return
AWA
Artemis Wealth Advisors New York $835M AUM 73.7% 1-Year Est. Return

HHLR Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, HHLR Advisors held 43 positions worth $4.47B, up 25% from $3.59B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

HHLR Advisors deployed $887M of net new capital in Q2 2019, opening 13 new positions and adding to 6 existing holdings. Its largest new stake was 58.com Inc: 2,360,742 shares worth $147M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Mondelez International, an estimated $24.3M trimmed.

  • HHLR Advisors's largest Q2 2019 buy was 58.com Inc: 2,360,742 shares worth $147M.
  • HHLR Advisors added most to New Oriental in Q2 2019, an estimated $152M increase.
  • HHLR Advisors's biggest Q2 2019 reduction was Mondelez International, cutting an estimated $24.3M.
  • HHLR Advisors's ten largest holdings make up 66% of its $4.47B portfolio in Q2 2019.
  • HHLR Advisors opened 13 new positions and closed 0 in Q2 2019.
  • HHLR Advisors's portfolio value rose 25% quarter-over-quarter to $4.47B.

Based on HHLR Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.